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The adenomatous polyposis coli (APC) I1307K allele is found in 6% of the Ashkenazi Jewish population and in
1%–2% of Sephardi Jews; it confers a relative risk of 1.5–2.0 for colorectal cancer (CRC) on all carriers. Within
the Ashkenazim, the existence of numerous high-prevalence mutations, including I1307K, has sparked controversy
over whether genetic drift or selection is the underlying cause. For the present population-based case-control study
of CRC in Israel, we tested whether selection has operated at I1307K. We also estimated the age of the I1307K
allele, to understand its origin in the context of the Jewish diasporas and subsequent founder events. We genotyped
83 matched pairs, in which one or both members of the pair carried I1307K, at three microsatellites and two SNPs.
Haplotypes were statistically constructed using PHASE software. Single-marker age estimates for I1307K were
calculated using the approach described by Risch et al. A common progenitor haplotype spanned across APC
I1307K from the centromeric marker D5S135 to the telomeric marker D5S346 and was observed in individuals
of Ashkenazi, Sephardi, and Arab descent. The ancestor of modern I1307K alleles existed 87.9–118 generations
ago (∼2,200–2,950 years ago). This age estimate indicates that I1307K existed at about the time of the beginning
of the Jewish diaspora, explaining its presence in non-Ashkenazi populations. Our data do not indicate that selection
operated at I1307K (D5S346, ; D5S135, ), providing compelling evidence that the high frequencyPp .114 Pp .373
of disease-susceptibility alleles in the Ashkenazim is due to genetic drift, not selection. This research underscores
the importance of the migratory patterns of ancestral populations in the ethnic and geographic distribution of APC
I1307K.
Introduction
Colorectal cancer (CRC) ranks third in the United States
in cancer incidence and second in Israel in cancer inci-
dence (Greenlee et al. 2000). Low-penetrance suscepti-
bility alleles may contribute significantly to the incidence
of CRC not explained by other known risk factors. The
low-penetrance susceptibility adenomatous polyposis coli
(APC [MIM 175100]) I1307K allele can be found in
6.1% of the Ashkenazi Jewish population, and it confers
a relative risk of 1.5–2.0 for CRC (Laken et al. 1997).
The APC allele with lysine (K) at codon 1307, commonly
referred to in the literature as I1307K, results from the
TrA transition at nt 3920 in APC, which causes an
extended mononucleotide tract (A8). This mononucle-
otide repeat impairs replication fidelity, forming a mu-
tational hotspot (Laken et al. 1997).
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Several studies have investigated the ethnic distribu-
tion of I1307K outside the Ashkenazim. An I1307K
carrier frequency of 1.3% was measured in 239 Israeli
Jews of non-European origin, which includes Oriental
Jews, North African Jews, and Sephardi Jews (Rozen et
al. 1999). Within this same study, 261 Ashkenazi Jews—
defined as Israeli Jews who primarily immigrated from
Russia, Poland, and Romania—had a carrier frequency
of 7.7%, which was significantly greater than the 1.3%
identified in Israeli Jews of non-European origin (P !
) (Rozen et al. 1999). Prior et al. subsequently stud-.01
ied 345 non-Ashkenazi Jewish individuals, including
black Americans, Italians, Finns, and Hawaiian-Japa-
nese; no I1307K carriers were identified (Prior et al.
1999). In addition, Drucker et al. determined that the
I1307K carrier frequency in Yemenite Jews is ∼4.7%
(Drucker et al. 2000).
Within the Ashkenazim, the existence of numerous
disease-susceptibility alleles in addition to I1307K—
including those for Tay-Sachs disease, Gaucher disease,
and torsion dystonia—has sparked controversy over
whether genetic drift or selection is the underlying cause
(Risch et al. 2003). Initially, evidence suggested that the
high frequency of lysosomal-storage disorders (LSDs),
such as Tay-Sachs disease and Gaucher disease, in the
Niell et al.: Genetic Anthropology of APC I1307K 1251
Ashkenazim was likely to reflect selection in favor of
heterozygous carriers. However, recent data demon-
strated that the increased prevalence of torsion dystonia
in the Ashkenazim is due to recent founder events, since
this autosomal dominant disorder is unlikely to be sub-
jected to heterozygote advantage (Risch et al. 1995,
2003). In the absence of selection, certain other del-
eterious alleles, such as APC I1307K, likely became
highly prevalent in the Ashkenazim because of the oc-
currence of one or more founder events during this pop-
ulation’s history. Within the Molecular Epidemiology
of Colorectal Cancer (MECC) study, a large population-
based case-control investigation of incident CRC, we
tested whether selective advantage has operated at
I1307K. Furthermore, we estimated the age of the
I1307K allele, tracing its exposure to founder events
throughout history and framing its current ethnic and
geographic distribution in the context of the Jewish
diasporas.
Material and Methods
Study Population
The MECC study is a population-based case-control
investigation of incident CRC cases collected in northern
Israel from March 31, 1998, to December 31, 2002.
Incident CRCs were identified via rapid case ascertain-
ment in five hospitals in northern Israel, and all CRC
cases for these analyses have histologically confirmed
cancer of the colon or rectum. The controls were iden-
tified from the Kupat Holim Clalit database and were
individually matched for exact year of birth, sex, clinic,
and Jewish versus non-Jewish heritage. Controls were
required to have no prior diagnosis of CRC. The study
was approved by the Institutional Review Boards at the
University of Michigan and Technion University. Writ-
ten, informed consent was required for eligibility. For
each MECC participant, blood, frozen tumor speci-
mens (if available), and paraffin-embedded tumor
specimens (if available) were collected, and an ex-
tensive interview was performed. The interview includes
information about religion, self-reported ethnic heritage,
and country of birth, as well as similar data for parents
and grandparents. Eligible participants from the MECC
study included all 83 case-control pairs, in which the case,
the control, or both members of the pair carried APC
I1307K. Two homozygous I1307K-positive cases, eight
positive cases without matched controls, and two positive
controls without matched cases were also genotyped.
Genotyping
Genomic DNA was extracted from whole blood, using
a commercially available kit, according to the manufac-
turer’s protocol (Puregene DNA extraction kit; Gentra
Systems). Samples were amplified in a 20-ml I1307K PCR
volume consisting of 40 ng genomic DNA, 2.0 mM
MgCl2, 200 mM dNTPs, 0.75 U AmpliTaq DNA poly-
merase, 165 nM I1307K-F forward primer, and 165 nM
I1307K-R reverse primer (table A [online only]). Ther-
mal cycling included an initial denaturation step of 95C
for 5 min, then 35 cycles of 1 min denaturing at 95C,
1 min annealing at 53C, and 1 min extension at 72C,
with a final 10-min extension step at 72C. Allele-specific
oligonucleotide (ASO) hybridization for I1307K was
performed as described elsewhere (Gruber 2001), with
two differences: (1) the hybridization and wash steps
were performed at 44C; and (2) the wild-type probe
was 5′-CTTTTCTTTTATTCTGC-3′, and the mutant
probe was 5′-CTTTTCTTTTTTTTCTGC-3′ (Gruber
2001). For D1822V genotyping, samples were amplified
in a 20-ml PCR volume that contained 100 ng genomic
DNA, 2.0 mM MgCl2, 200 mM dNTPs, 1.0 U AmpliTaq
DNA polymerase, 491 nM primer D1822V-F, and 490
nM primer D1822V-R (table A [online only]). Thermal
cycling was similar to that described above for I1307K,
except the annealing step was performed at 54C. ASO
hybridization for D1822V was adapted from the above
protocol for APC I1307K, with two differences: (1) the
hybridization and wash steps were performed at 51.5C;
and (2) the wild-type probe was 5′-ATTCCAAGGACT-
TCAATGAT-3′, and the mutant probe was 5′-ATTCCA-
AGGTCTTCAATGAT-3′. For D5S135 genotyping, the
20-ml PCR analysis was performed as described above
for the D1822V PCR analysis, except for the following:
(1) 482 nM D5S135-F primer and 500 nM D5S135-R
primer were used; and (2) the annealing step was per-
formed at 60C (table A [online only]). ASO hybridi-
zation was performed, with three differences: (1) the
hybridization was done at 52C; (2) the wash step was
done at 51.5C; and (3) different probes were used (the
wild-type probe was 5′-TATGGAGAAGGCTCACTG-
3′, and the mutant probe was 5′-TATGGAGAAGCCT-
CACTG-3′) (Gruber 2001). For D5S82, D5S346, and
D5S122 genotyping, a 20-ml multiplex PCR volume con-
tained 40 ng genomic DNA, 2.0 mM MgCl2, 200 mM
dNTPs, 1.0 U AmpliTaq DNA polymerase, 11 nM 32P
end-labeled primer D5S82-R, 12 nM 32P end-labeled
primer D5S122-F, 11 nM 32P end-labeled primer D5S346-
F, 164 nM primer D5S82-F, 160 nM primer D5S122-R,
and 130 nM primer D5S346-R (table A [online only]).
Thermal cycling was similar to that for I1307K above
except the annealing step was performed at 55C. The
radioactively labeled PCR products were then run on a
denaturing acrylamide gel electrophoretic system and
were analyzed by autoradiography.
Haplotype Determination
Haplotypes were estimated for each member of all 83
matched pairs, using PHASE, version 1.0 (Stephens et
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al. 2001). PHASE, a Bayesian Markov chain–Monte
Carlo algorithm, incorporates coalescent theory to de-
velop haplotype prior probabilities (Stephens et al. 2001).
Because the I1307K-positive chromosomes shared a re-
gion surrounding I1307K, a common “progenitor hap-
lotype” was identified from the marker loci that showed
conserved marker alleles within the shared region. Ge-
notypes of the four homozygous I1307K carriers were
examined to identify a putative progenitor haplotype for
comparison with PHASE output.
Statistical Analyses
x2 tests were performed for each marker locus with
one or more putative progenitor alleles. Putative pro-
genitor alleles were compared with all other alleles at
the marker locus in I1307K-negative versus I1307K-pos-
itive chromosomes and were classified in a 2# 2 table,
and a x2 test was performed (Risch et al. 1995). The
present analysis examines each haplotype regardless of
whether it is observed in cases or controls, and therefore
an unmatched analysis is appropriate. x2 tests were con-
ducted using SAS, version 8.02 (SAS Institute).
Linkage Disequilibrium
Methods for calculating linkage disequilibrium (LD)
have been described elsewhere (Risch et al. 1995). The
LD statistic d was used for each marker, since d estimates
the proportion of I1307K chromosomes with the pro-
genitor marker allele (Devlin and Risch 1995; Risch et
al. 1995). Let pD be the proportion of I1307K chro-
mosomes carrying the progenitor allele at the marker
locus, and let pN be the proportion of non-I1307K chro-
mosomes carrying the progenitor allele at the marker
locus, then .dp (p  p )/(1 p )D N N
Estimation of Allele Age by Use of a Single-Marker
Locus
Allele age can be estimated by analyzing the sequence
variability surrounding the allele of interest. Intra-allelic
variability refers to the variations in sequence at closely
linked polymorphic markers among alleles containing
the mutation or polymorphism whose age is in question.
Starting at the time of the mutation that created the
polymorphism itself, recombination and mutation in
subsequent generations break down the initially perfect
LD between the polymorphism and the progenitor alleles
at nearby markers, thereby creating intra-allelic varia-
bility (Slatkin and Rannala 2000). This analytical ap-
proach to aging has been described elsewhere (Risch et
al. 1995). In brief, allele age in number of generations
is related to the observed frequency of I1307K-bearing
chromosomes not carrying the progenitor marker allele,
the frequency (pN) of the progenitor marker allele on
I1307K noncarrier chromosomes, and the recombina-
tion fraction v between the marker allele and I1307K:
ˆlog [(1Q)/(1 p )]Ngˆp ,( )log 1 v
where g is the number of generations, and is the ob-ˆQ
served frequency of I1307K. The marker(s) used in this
calculation must demonstrate at least one ancestral allele
in strong association with I1307K, but the marker allele
cannot be in perfect linkage equilibrium with I1307K
(i.e., some recombinations must exist). Because of the
small genetic distances involved, the calculated recom-
bination fractions of the Kosambi and Haldane map
functions differed by !0.5%, so we report age estimates
that incorporate recombination fractions calculated from
the Kosambi map function (Haldane 1919; Kosambi
1944). In addition, recombination fraction estimates
for D5S346 and D5S135 with respect to APC have
been estimated elsewhere, so we report age estimates
calculated from these estimates (Nakamura et al. 1988;
Olschwang et al. 1995).
Because the above approach accounts primarily for
recombination, we also estimated the age of the most
recent common ancestor of I1307K by using BATWING
(Bayesian analysis of trees with internal node generation)
software, which incorporates the effects of demographic
and mutation processes (Wilson and Balding 1998).
BATWING is a Markov chain–Monte Carlo algorithm
that uses coalescent theory to generate genealogical trees
underlying the sample that are consistent with the sam-
ple haplotypes and specified demographic model (Wilson
and Balding 1998). The tree height from the generated
genealogical trees translates to the time of the most
recent common ancestor of I1307K. Two-locus hap-
lotypes, consisting of D5S346 and I1307K, were input
into the program, and the stepwise mutation rate for
D5S346 was allowed to vary between 0.00028 and
0.0005, according to microsatellite mutation rate data
reported by Chakraborty et al. (1997). The specified
demographic model assumed exponential growth at a
rate of 0.4055, beginning 350 years (14 generations)
ago, from a constant-sized ancestral population (Risch
et al. 1995). A generation time of 25 years was assumed.
Labuda Correction Factor
A simple approximation for the intra-allelic genealogy
assumes a star genealogy, in which all lineages descend
independently from the same ancestral allele, so all co-
alescent times are identical (Slatkin and Rannala 2000).
The star genealogy is a reasonable simplification in a
very rapidly growing population, such as the Jewish pop-
ulation for the 200 years after 200 BC (Slatkin and Hud-
son 1991; Barnavi 1992; Reich and Goldstein 1999).
However, even slight deviations from a starlike geneal-
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Table 1
Demographic Data for 83
Matched Pairs
Individual, APC I1307K
Status, and Ethnicity n
Case:
Positive:
Ashkenazi 52
Sephardi 1
Homozygous positive:
Ashkenazi 1
Negative:
Ashkenazi 24
Sephardi 2
Arab 2
Unknown 1
Control:
Positive:
Ashkenazi 27
Sephardi 1
Arab 2
Homozygous positive:
Ashkenazi 1
Negative:
Ashkenazi 39
Sephardi 13
Figure 1 Representative genotypes of APC I1307K carriers. A,
Conserved allele at D5S346 among I1307K carriers observed among
Ashkenazi Jews (lanes 1–3), Sephardi Jews (lanes 4–6), and Arabs
(lanes 7–9) (arrow). B, Absence of conserved genotype at D5S82
among Ashkenazi Jews (lanes 1–3), Sephardi Jews (lanes 4–6), or Arabs
(lanes 7–9).
ogy can introduce a downwardly biased allele age esti-
mate (Slatkin and Rannala 2000). Labuda et al. (1996)
present a correction factor for the allele age point esti-
mate, assuming a synchronously bifurcating genealogy.
The age estimate from Risch’s approach will be increased
by adding the factor , where r isr r{(1/r) ln [ve /(e  1)]}
the growth rate of the population and v is the recom-
bination fraction between APC and the marker used for
Risch’s allele-age estimate (Slatkin and Rannala 2000).
In accordance with census estimates of the Jewish pop-
ulation between 200 BC and AD 0, we used a growth
rate of ∼1.125-fold per generation (ln 1.125 p 0.1178
p r), corresponding to the population growth during
the period in which the most recent common ancestor
of I1307K is hypothesized to have existed (i.e., approx-
imately the beginning of the Jewish diasporas) (Barnavi
1992).
Test for Selection
Slatkin and Bertorelle (2001) developed a method to
test neutrality by examining whether the observed intra-
allelic variability is consistent with the allele frequency,
given two periods of exponential population growth.
The Ashkenazim have experienced at least two periods
of massive population growth, separated by ∼1,500
years during which no net population growth occurred.
We adapted code from Slatkin and Bertorelle’s double
exponential model (kindly provided by M. Slatkin) to
allow three periods of exponential growth. From 200
BC to AD 0, the worldwide Jewish population increased
from 500,000 to 4.5 million. If an average generation
of 25 years is assumed, this increase gives a growth rate
over this period of 1.125-fold per generation (r3 p ln
1.125p 0.1178). Until the mid 1600s, the Jewish pop-
ulation experienced a series of expansions and contrac-
tions, but no major phases of population growth oc-
curred, so we assigned r2 to be 0.001 (Slatkin 2000).
From the 16th to the 19th centuries, the Ashkenazi pop-
ulation underwent an enormous expansion, with a
growth rate of 1.5-fold per generation (r1 p ln 1.5 p
0.4055) (Risch et al. 1995). Input parameters for the
triple exponential model were derived from our Ash-
kenazi data, under the assumption of a 6% carrier fre-
quency of I1307K in the general Ashkenazi population,
the dinucleotide microsatellite mutation rate for D5S346
of 0.0005 from Chakraborty et al. (1997), the popu-
lation growth estimates outlined above, as well as the
effective Ashkenazi population size outlined by Slatkin
(2000).
Results
The demographic characteristics of cases and controls
are shown in table 1. Of the 85 I1307K-positive indi-
viduals, 81 (95.3%) are Ashkenazi Jews, including both
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Figure 2 Conserved alleles at markers linked to I1307K. These
alleles, shown for homozygous positive individuals, construct a pu-
tative progenitor haplotype of the most recent common ancestor of
I1307K.
Table 2
Putative Progenitor Marker Alleles on APCI1307K-Positive
Haplotypes
Locus, Putative
Progenitor Allele,
and Ethnicity
No. of Haplotypes
with Putative
Progenitor
Marker Allele
No. of Haplotypes
with Marker
Alleles Other
Than Progenitor
D5S82:
175 bp:
Ashkenazi 34 49
Sephardi 1 1
Arab 1 1
D5S82:
181 bp:
Ashkenazi 26 57
Sephardi 1 1
Arab 1 1
D5S122:
213 bp:
Ashkenazi 72 11
Sephardi 1 1
Arab 0 2
D5S135:
A1:
Ashkenazi 79 4
Sephardi 2 0
Arab 2 0
D1822V:
D:
Ashkenazi 82 1
Sephardi 2 0
Arab 2 0
D5S346:
10:
Ashkenazi 81 2
Sephardi 2 0
Arab 2 0
homozygous positive individuals; 2 (2.4%) are Sephardi
Jews; and 2 (2.4%) are Arabs (table 1).
Genotyping data demonstrated conserved alleles at
certain marker loci surrounding I1307K. Individuals
carrying I1307K share a common allele at the micro-
satellite marker D5S346 (fig. 1A), but they do not share
a common allele at the microsatellite marker D5S82 (fig.
1B), indicating that the progenitor haplotype of the
most recent common ancestor of modern-day I1307K
alleles incorporates D5S346 but not D5S82. To further
identify which markers harbor conserved alleles across
I1307K carriers, we evaluated the genotypes of four
I1307K-positive homozygotes. All four homozygotes
shared the 213-bp allele at D5S122, the A1 allele
at D5S135, the D (aspartic acid–encoding) allele
at D1822V, and the 10 allele at D5S346 (fig. 2).
At D5S82, each homozygote carried one copy of the
175-bp allele and one copy of the 181-bp allele (fig. 2).
After constructing haplotypes for each individual
within the 83 matched pairs, we analyzed the number
of I1307K-positive haplotypes that carried the pu-
tative progenitor marker alleles suggested by the ge-
notyping data of the I1307K homozygotes. Of the 87
I1307K-positive haplotypes, 73 (83.9%) at D5S122, 83
(95.4%) at D5S135, 86 (98.9%) at D1822V, and 85
(97.7%) at D5S346 carried the same marker alleles (ta-
ble 2). At D5S82, 36 (41.4%) carried the 175-bp allele,
and 28 (32.2%) carried the 181-bp allele. These puta-
tive progenitor alleles are consistent across ethnic her-
itage (table 2).
x2 analyses were performed to formally test whether
each marker’s putative progenitor allele was more com-
mon on I1307K-positive haplotypes than on I1307K-
negative haplotypes (table 3). The A1 allele at D5S135
was significantly more prevalent on I1307K-positive
haplotypes ( ), as were the D allele and the 10Pp .002
allele at D1822V and D5S346, respectively ( ).P ! .0001
Each of the markers—D5S135, D1822V, and D5S346—
demonstrates high LD with I1307K (table 3). At D5S82,
the 175-bp allele, but not the 181-bp allele, was sig-
nificantly more prevalent on I1307K-positive haplo-
types ( ). However, at D5S122, which is locatedPp .05
between I1307K and D5S82, no allele was found more
commonly among I1307K carriers ( ) (fig. 2).Pp .898
Both D5S82 and D5S122 demonstrate low LDs with
I1307K (table 3). These data indicate that the I1307K
progenitor haplotype spans across APC I1307K from
the centromeric marker D5S135 to the telomeric marker
D5S346, constituting a physical distance of∼500,000 bp.
Because a balance between high LD and sufficient
recombination is required for age estimation via the
intra-allelic variability approach, single-marker age es-
timates for I1307K could be calculated with data from
markers D5S135 and D5S346, using recombination
fractions obtained from the Kosambi map function
(table 4). On the basis of the data at D5S135 without
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Table 3
Analyses of Putative Progenitor Marker Alleles in APC I1307K Carrier and Noncarrier
Haplotypes
Locus (Allele)
No. of Carriers/
Noncarriers
of Putative Progenitor
Allele in I1307K
No. of Carriers/
Noncarriers
of All Other Alleles
in I1307K Pa d
D5S82 (175 bp) 36/73 51/172 .048 .165
D5S82 (181 bp) 28/94 59/151 .304 .1
D5S122 (213 bp) 73/207 14/38 .898 .038
D5S135 (A1) 83/199 4/46 .002 .755
D1822V (D) 86/187 1/58 !.0001 .951
D5S346 (10) 85/32 2/213 !.0001 .974
a By x2 analysis.
Table 4
APC I1307K Age Estimates
Characteristic D5S135 D5S346
Physical distance (kb) 460 38.5
Kosambi-calculated v .0046 .000385
Age estimate (in generations) 60.9 69.5
Age estimate (in years)a 1,523 1,738
Date of most recent common ancestor 480 AD 265 AD
Adjusted age estimate (in generations)b 87.9 118
Adjusted age estimate (in years)a,b 2,198 2,950
Adjusted date of I1307K most recent
common ancestor b 195 BC 947 BC
a Calculated from the age estimate in generations, assuming a 25-
year generation.
b Incorporates the Labuda correction factor.
the Labuda correction, the most recent common ances-
tor of present-day I1307K alleles existed 60.9 genera-
tions ago (AD ∼480). Given the data at D5S346 and
without the Labuda correction, the most recent com-
mon ancestor of present-day I1307K alleles existed 69.5
generations ago, (AD ∼265). When the data at D5S135
are analyzed using the Labuda correction, the most
recent common ancestor of present-day I1307K al-
leles dates to 87.9 generations ago (∼195 BC); and
at D5S346, the Labuda-adjusted age estimate is 118
generations (∼947 BC).
Because recombination rate is one of the major
sources of uncertainty inherent in these calculations,
table 5 presents the age estimates for the most recent
common ancestor of present-day I1307K alleles within
our study population at varying recombination rates.
At D5S135, a recombination rate of 0.002, half the
recombination rate calculated from the Kosambi map
function, suggests an age estimate of 140.3 generations
ago, which corresponds to 1505 BC. If the Kosambi-
calculated recombination fraction is doubled, to 0.009,
it provides an age estimate of 31.1 generations ago
(∼777 years ago). Varying the recombination fraction
at D5S346 yielded similar results (table 5). Use of the
recombination fractions previously reported in the lit-
erature gave estimates indicating very recent origin of
the allele: the recombination fraction of 0.05 at D5S346
indicated that the most recent common ancestor of
I1307K existed in AD 1990, and the recombination frac-
tion of 0.02 at D5S135 indicated that the most recent
common ancestor existed in AD 1655 (table 5).
Given the low recombination rate between D5S346
and I1307K, mutation might be an important factor
underlying the intra-allelic variability observed in our
data. In addition, modeling the demographic history of
the population, such as population growth and size,
might have significant impact on the intra-allelic ge-
nealogy of I1307K used to estimate allelic age. When
demographic and mutation processes were incorpo-
rated, the BATWING algorithm estimated that the most
recent common ancestor of I1307K existed 2,490 years
ago (∼487 BC).
Age estimates can also be affected by the presence of
selection. We tested whether selection was operating at
I1307K by examining whether the observed number of
I1307K progenitor haplotypes within the Ashkenazi
carriers is consistent with the population frequency of
the I1307K allele within the Ashkenazi population as a
whole. At D5S346 or D5S135, the data do not allow
us to reject neutrality ( and , re-Pp .114 Pp .373
spectively). Therefore, we conclude that our data do
not suggest selection at I1307K.
Because of the small number of non-Ashkenazi I1307K
carriers among our 83 matched pairs, we genotyped 10
additional unmatched I1307K carriers, consisting of 8
cases and 2 controls. All 10 of these I1307K carriers
share the I1307K progenitor haplotype, spanning across
APC from D5S135 to D5S346. Table 6 shows the ethnic
heritage of each individual included in this combination
of 10 non-Ashkenazi I1307K carriers with the 2 Se-
phardi and 2 Arab I1307K carriers from our matched-
pair data. These data indicate that the conserved
I1307K haplotype exists in individuals from various
ethnic backgrounds and geographical locales, including
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Table 5
Sensitivity Analysis of APCI1307K Age Estimates to Varying
Recombination Fractions
Locus and v
No. of
Generationsa Yearb
D5S135:
vkosambip .0046 60.9 481 AD
vliterature
cp .02 13.9 1655 AD
vlow
dp .002 140.3 1505 BC
vhigh
ep .04 6.9 1830 AD
D5S346:
vkosambip .000385 69.5 265 AD
vliterature
fp .05 .52 1990 AD
vlow
dp .0002 134.0 1347 BC
vhigh
ep .0008 33.5 1165 AD
a Without the Labuda correction factor.
b Calculated from the age estimate in generations, assuming a 25-
year generation.
c Recombination fraction between APC and D5S135 reported by
Olschwang et al. (1995).
d vlow is half of the lowest estimated recombination fraction, either
from the literature or the Kosambi map function calculations.
e vhigh is twice the highest estimated recombination fraction, either
from the literature or the Kosambi map function calculations.
f vliterature is the recombination fraction between APC and D5S346
reported by Nakamura et al. (1988).
Yemen, Syria, France, Argentina, Morocco, Egypt, Tur-
key, Palestine, and Israel.
Discussion
The low prevalence of I1307K in non-Ashkenazi Jews,
compared with the high prevalence within the Ashke-
nazim, suggests one or a combination of three possible
explanations: (1) genetic exchange recently occurred, (2)
the non-Ashkenazi I1307K carriers have at least one
Ashkenazi I1307K-carrying ancestor, or (3) the I1307K
mutation preceded or coincided with the Jewish dias-
poras and was followed by a founder effect specifically
in the Ashkenazim. The diasporas refer to the settling
of scattered colonies of Jews outside the area of Jeru-
salem and vicinity. Our research indicates that the most
recent common ancestor of present-day I1307K alleles
likely existed between 947 BC and 195 BC. Let us con-
sider this range of age estimates within the framework
of Jewish history (fig. 3). The fall of Jerusalem in 586
BC to the Babylonian empire spurred the exile of Jews,
primarily to Mesopotamia and the banks of the Nile
(figs. 3 and 4) (Barnavi 1992). In 301 BC, Ptolemy I
conquered Jerusalem in the name of the Greek Empire
and deported large numbers of Jews to Egypt. From 301
BC to 63 BC, Jews continued moving into Egypt, as well
as into the present-day areas of Syria, Turkey, and Greece
(fig. 4). Following the conquest of Jerusalem by the Ro-
man Empire’s General Pompey, in 63 BC, many Jews fled
to regions of present-day Italy and northern Africa. The
Great Revolt against Rome and the fall of Jerusalem in
AD 66–73 caused the destruction of the Second Temple
by Titus and the continuation of the diaspora (fig. 4).
In AD 135, Emperor Trajan’s forces quelled the Bar
Kokhba Revolt in Palestine. This event precipitated nu-
merous persecutions of Jews, which resulted in hundreds
of thousands of deaths, as well as the almost total
destruction of Jewish communities in Alexandria and
northern Africa. Starting in the 1st century AD, small
Jewish communities existed in Europe as far north as
London; Jewish communities were also present as far
west as northern Africa and as far east as western Asia
(Barnavi 1992) (fig. 4). However, it was only in the mid-
10th century that the Jewish communities destined to
become Ashkenazi migrated from southern Europe
into the regions of France and Germany (Barnavi 1992).
Given this history, the observation that I1307K can be
found in non-Ashkenazi individuals is not surprising,
because the most recent common ancestor of modern-
day I1307K alleles existed sometime between 947 BC
and 195 BC, before or near the beginning of the Jewish
diaspora. The age estimate for APC I1307K—and its
resulting presence in both Ashkenazim and non-Ash-
kenazim—is consistent with the age estimates and ethnic
distributions of other mutations found primarily in Jew-
ish individuals. BRCA1 (MIM 113705) 185delAG dates
to 46 generations ago, after the diasporas, and this mu-
tation is found almost exclusively in Ashkenazi individ-
uals (Neuhausen et al. 1996). However, the most recent
common ancestor for the F11 (MIM 264900) E117X
mutation causing factor XI deficiency type II existed 120
generations ago, before the diasporas, and this mutation
is observed in both Ashkenazi and non-Ashkenazi in-
dividuals today (Goldstein et al. 1999).
APC I1307K likely represents an example of an allele
achieving a high frequency in the Ashkenazim via ge-
netic bottleneck due to the rapid growth of the Ash-
kenazi population from a small group of founders. The
Cossack massacres in 1648–1649 devastated the pri-
marily Ashkenazi Jewish populations living in Poland
and Lithuania, with ∼25% of the existing population
killed (Weinryb 1972; Barnavi 1992). The census of
1765 estimated that 430,000 Jews lived in Poland and
130,000 lived in Ukraine (Weinryb 1972). By 1900,
there were 5 million Jews living in these regions, in-
dicating that the population increased ∼10-fold dur-
ing these 135 years (Weinryb 1972; Risch et al. 1995).
Given massive population growth from a small founder
population at least once in the history of the Ashke-
nazim, the higher prevalence of I1307K in Ashkenazi
Jews than in other Jewish populations is consistent with
genetic drift alone and does not require the forces of
natural selection. CRC primarily affects individuals
who are past reproductive age, with an average age at
onset of 70.2 years in Ashkenazi I1307K carriers, so
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Table 6
Ethnic and Geographic Origin of 13 Non-Ashkenazi APC I1307K
Carriers in the MECC Study
BIRTH COUNTRY OF
ETHNIC
HERITAGE
MECC
Participant Father Mother
Sephardi Argentina Syria Syria
Sephardi Egypt Syria Egypt
Sephardi Morocco Morocco Morocco
Sephardi Syria Syria Syria
Sephardi France France France
Sephardi Egypt Egypt Egypt
Sephardi Turkey Turkey Turkey
Sephardi Israel Yemen Yemen
Sephardi Palestine Palestine Palestine
Sephardi Israel Syria Syria
Christian Arab Israel Palestine Palestine
Muslim Arab Palestine Palestine Palestine
Muslim Arab Palestine Palestine Palestine
NOTE.—Information about origin was not available for 1 of the 14
non-Ashkenazi I1307K carriers.
Figure 3 Timeline of selected events in the history of the Jewish peoples
selection is unlikely to be responsible for the high allele
frequency of APC I1307K (Gryfe et al. 1999; Stern et
al. 2001). However, it is arguable that some unknown
effect of I1307K could lead to selection for or against
the polymorphic allele. To investigate this possibility,
we tested the neutrality of I1307K, using the technique
developed by Slatkin and Bertorelle (2001), and found
no evidence of selection. To investigate genetic drift ver-
sus selection as the primary cause of highly prevalent
disease mutations in the Ashkenazim, Risch and col-
leagues (2003) recently compared mutations causing
LSDs to mutations causing non–lysosomal-storage dis-
eases (NLSD), including Bloom syndrome, cystic fibro-
sis, and familial hypercholesterolemia, among others.
That study identified no differences between the LSD
and the NLSD with respect to the number of mutations,
the allele-frequency distributions, or the estimated ages
of mutations. Those data indicate that genetic drift due
to two founder events (one ∼11 centuries ago and an-
other ∼5 centuries ago), rather than selection, is the
most likely explanation for the high frequency of disease
mutations in the Ashkenazim (Risch et al. 2003). Our
data provide further evidence that genetic drift, not nat-
ural selection, is the primary mechanism causing the
high prevalence of disease mutations in the Ashkenazim.
The analytical approach used in this research presents
a technique to estimate allele age by utilizing intra-allelic
variability data. This statistical method has two crucial
features. First, the age estimated is that of the most
recent common ancestor of all present-day allele copies,
not the age(s) of the I1307K mutation event(s). It is
possible that many I1307K mutation events have oc-
curred, but we assume that only one event led to all
descendant alleles currently in the population. Second,
no demographic assumptions, such as the structure of
population growth, are required to estimate allele age,
although they can be incorporated when using the BAT-
WING algorithm (Wilson and Balding 1998; Slatkin
and Rannala 2000).
However, two assumptions are required for the intra-
allelic variability aging method to accurately determine
the age of the most recent common ancestor of I1307K.
First, it is assumed that recombination, not mutation,
causes the decay of LD. Second, the method assumes
that a progenitor haplotype can be established. The hap-
lotypes in the present study were statistically derived
using PHASE; therefore, errors in haplotype determi-
nation are possible. However, because our analyses used
pairwise comparisons, our results are robust to hap-
lotyping error. When comparing haplotype error in
PHASE to the EM algorithm, Stephens et al. (2001)
demonstrated that PHASE reduced error rates by 14%–
69% when applied to genotypes from pedigree data
with unambiguous phase or when applied to molecu-
larly determined haplotypes. While we were establishing
the progenitor haplotype, it became evident that the
majority of I1307K-positive chromosomes had one of
two marker alleles at D5S82 but that no conserved allele
1258 Am. J. Hum. Genet. 73:1250–1260, 2003
Figure 4 The Jewish diasporas. The existence of APC I1307K prior to the Jewish diasporas explains its presence in non-Ashkenazi peoples
residing in geographic locales populated by the diasporas. Adapted from Barnavi (1992).
was present at D5S122, which is located closer to
I1307K. It is likely that, soon after the I1307K poly-
morphism event, recombination occurred near D5S82,
creating I1307K haplotypes with either a 3 allele or a
6 allele at D5S82. Subsequent generations of mutation
and recombination have further broken down the LD
between D5S82 and I1307K. We concluded that, be-
cause no conserved allele exists at D5S122, the present-
day I1307K progenitor haplotype spans the distance
from the centromeric marker D5S135 to the telomeric
marker D5S346. This conclusion is likely to be valid,
because a common four-marker haplotype containing
the I1307K allele in Ashkenazi and Yemenite Jews has
been described elsewhere (Patael et al. 1999). This re-
ported progenitor haplotype includes three APC intra-
genic markers and D5S346; however, it excludes D5S82,
and it was found in 41% of unselected Ashkenazi Jews
and 23.4% of unselected Yemenite Jews (Patael et al.
1999).
Because the intra-allelic variability technique used to
estimate the age of I1307K relies on the LD statistic
and the recombination fraction between I1307K and
the marker of interest, errors in either or both of these
calculations could significantly alter results. Our LD sta-
tistic d incorporates pD, the proportion of I1307K chro-
mosomes carrying the progenitor allele at the marker
locus, and pN, the proportion of noncarrier chro-
mosomes carrying the progenitor allele at the marker
locus. Both pD and pN were derived from our sample
data, but pN could also be determined from other
sources. For D5S346, the CEPH reports an allele 10
frequency of 0.206, compared with .131 within our
data. Given a value of 0.206 for pN, the I1307K age
estimate, without the Labuda correction, becomes
76.3 generations instead of 69.5 generations. At
D5S135, Olschwang et al. (1995) defined an allele fre-
quency of 0.8 for the A1 allele, giving a Labuda-un-
adjusted age estimate of 56.7 generations, compared
with 60.9 generations from our data. These virtually
identical age results indicate that our study population
provides reasonable estimates of the proportion of non-
carrier chromosomes carrying the progenitor allele at
the marker locus, and, therefore, our LD calculations
are unlikely to adversely affect the allele age estimates.
However, age estimates are exquisitely sensitive to re-
combination fraction estimates. The marker loci used
in these analyses are so tightly linked that recombina-
tion fractions cannot be accurately estimated from ge-
netic analyses, so recombination fractions were calcu-
lated using the Kosambi map function. Because these
calculations do not accurately reflect the true recom-
bination fractions either, we reported age estimates from
a range of recombination fractions consistent with avail-
able data, as was done by Serre et al. (1990), instead
of presenting SE estimates. This sensitivity analysis dem-
onstrates that varying the recombination fractions two-
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fold provides drastically different age estimates. If the
hypothesis that the most recent common ancestor of
I1307K preceded the Jewish diasporas is correct, it
would be difficult to distinguish which of the age es-
timates before the diaspora of the First Temple period
(586 BC) through the diaspora of the Second Temple
period (AD 70) was most accurate, because it would be
difficult to distinguish their outcomes by use of the eth-
nic distribution of I1307K today. Furthermore, an age
estimate more recent than the Cossack massacres in
1648–1649 is unlikely, because a founder effect is
likely responsible for the high prevalence of I1307K in
the Ashkenazim, especially given that there is no evi-
dence of selection at I1307K.
Because the I1307K ancestor likely existed during a
time when the Jewish population size increased dra-
matically, the I1307K age estimate is biased toward a
more recent date (unless corrected) (Labuda et al. 1996).
In the 200 years after 200 BC, the Jewish population
increased in size, from ∼500,000 to ∼4.5 million (Barnavi
1992). Because this was a rapidly growing population,
recombination events involving the I1307K polymor-
phism that occurred in early generations were less likely
than those in later generations, according to Luria-Del-
bruck theory (Labuda et al. 1996). Therefore, the omis-
sion of the contribution of these early generations pro-
duces an estimate of the likely number of recombinants,
which is the basis for the Labuda correction factor in-
corporated into our calculations. However, it is likely
that the census estimates are inaccurate, and it is pos-
sible that the Jewish population size did not increase as
drastically as was assumed in our calculations. It is note-
worthy that a smaller population growth rate would
increase the Labuda correction factor, which would sug-
gest that the most recent common ancestor of I1307K
existed earlier than our calculations indicated.
The impact of I1307K on CRC incidence is substan-
tial in the Ashkenazim, with a population-attributable
fraction of ∼5% in this group. However, the impact of
I1307K is less studied in other Jewish populations. Al-
though further studies are needed to examine the value
of presymptomatic testing for I1307K, understanding
the evolution of APC I1307K might enable health care
providers to better understand which individuals should
eventually be offered genetic testing in a clinical setting.
Because a conserved I1307K haplotype is shared among
Jews and Arabs and because the allele age of I1307K
indicates that the most recent ancestor of I1307K ex-
isted sometime between 947 BC and 195 BC (prior to
the Jewish diasporas), future genetic testing for this
polymorphism might be offered to Jewish individuals
as well as members of other ethnic populations (Patael
et al. 1999). Furthermore, the understanding that APC
I1307K did not achieve its high frequency within the
Ashkenazim via selective pressure provides additional
evidence that genetic drift is the primary cause of the
high prevalence of disease mutations, including I1307K,
within the Ashkenazim.
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